Skip to main content
Erschienen in: Heart and Vessels 2/2017

11.07.2016 | Case Report

Prominent QTc prolongation in a patient with a rare variant in the cardiac ryanodine receptor gene

verfasst von: Yuki Taniguchi, Aya Miyazaki, Heima Sakaguchi, Yousuke Hayama, Norihiro Ebishima, Jun Negishi, Kanae Noritake, Yoshihiro Miyamoto, Wataru Shimizu, Takeshi Aiba, Hideo Ohuchi

Erschienen in: Heart and Vessels | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

We report the case of a 12-year-old female patient with a history of four syncopal episodes related to exercise over 2 years and who showed prominent QTc prolongation on electrocardiogram; therefore, she was clinically diagnosed with long QT syndrome type-1. However, genetic analysis did not identify any LQT-related genes but showed a rare missense variant in the cardiac ryanodine receptor gene. From the results of drug-loading tests, administration of oral propranolol was initiated; thereafter, she experienced no syncopal episodes. This is a case report demonstrating the “overlapping clinical features” of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia.
Literatur
1.
Zurück zum Zitat Sumitomo N (2013) Progress of inherited arrhythmia. Jpn Pediatr Soc 117:1079–1092 (in Japanese) Sumitomo N (2013) Progress of inherited arrhythmia. Jpn Pediatr Soc 117:1079–1092 (in Japanese)
2.
Zurück zum Zitat Arakawa J, Hamabe A, Aiba T, Nagai T, Yoshida M, Touya T, Ishigami N, Hisadome H, Katsushika S, Tabata H, Miyamoto Y, Shimizu W (2015) A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia. Heart Vessel 30:835–840CrossRef Arakawa J, Hamabe A, Aiba T, Nagai T, Yoshida M, Touya T, Ishigami N, Hisadome H, Katsushika S, Tabata H, Miyamoto Y, Shimizu W (2015) A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia. Heart Vessel 30:835–840CrossRef
3.
Zurück zum Zitat Monteforte N, Priori SG (2009) The long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. Pacing Clin Electrophysiol 32:S52–S57CrossRefPubMed Monteforte N, Priori SG (2009) The long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. Pacing Clin Electrophysiol 32:S52–S57CrossRefPubMed
4.
Zurück zum Zitat Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, Mannens MMAM, Wilde AAM, Ackerman MJ (2009) Comprehensive open reading frame mutational analysis of the RyR2-encoded ryanodine receptor/calcium channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome. J Am Coll Cardiol 54:2065–2074CrossRefPubMedPubMedCentral Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, Mannens MMAM, Wilde AAM, Ackerman MJ (2009) Comprehensive open reading frame mutational analysis of the RyR2-encoded ryanodine receptor/calcium channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome. J Am Coll Cardiol 54:2065–2074CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Tester DJ, Kopplin LJ, Will ML, Ackerman MJ (2005) Spectrum and prevalence of cardiac ryanodine receptor mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2:1099–1105CrossRefPubMed Tester DJ, Kopplin LJ, Will ML, Ackerman MJ (2005) Spectrum and prevalence of cardiac ryanodine receptor mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2:1099–1105CrossRefPubMed
6.
Zurück zum Zitat Shigemizu D, Aiba T, Nakagawa H, Ozaki K, Miya F, Satake W, Toda T, Miyamoto Y, Fujimoto A, Suzuki Y, Kubo M, Tsunoda T, Shimizu W, Tanaka T (2015) Exome analyses of long QT syndrome reveal candidate pathogenic mutations in calmodulin-interacting genes. PLoS One 10(7):e0130329CrossRefPubMedPubMedCentral Shigemizu D, Aiba T, Nakagawa H, Ozaki K, Miya F, Satake W, Toda T, Miyamoto Y, Fujimoto A, Suzuki Y, Kubo M, Tsunoda T, Shimizu W, Tanaka T (2015) Exome analyses of long QT syndrome reveal candidate pathogenic mutations in calmodulin-interacting genes. PLoS One 10(7):e0130329CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Kauferstein S, Kiehne N, Erkapic D, Schmidt J, Hamm CW, Bratzke H, Pitschner HF, Kuniss M, Neumann T (2011) A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS. Int J Cardiol 146(2):249–250CrossRefPubMed Kauferstein S, Kiehne N, Erkapic D, Schmidt J, Hamm CW, Bratzke H, Pitschner HF, Kuniss M, Neumann T (2011) A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS. Int J Cardiol 146(2):249–250CrossRefPubMed
8.
Zurück zum Zitat Schwartz PJ, Crotti LJ (2011) QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 124:2181–2184CrossRefPubMed Schwartz PJ, Crotti LJ (2011) QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 124:2181–2184CrossRefPubMed
9.
Zurück zum Zitat Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S (2004) Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 1(3):276–283CrossRefPubMed Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S (2004) Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 1(3):276–283CrossRefPubMed
10.
Zurück zum Zitat Kimura H, Zhou J, Kawamura M, Itoh H, Mizusawa Y, Ding WG, Wu J, Ohno S, Makiyama T, Miyamoto A, Naiki N, Wang Q, Xie Y, Suzuki T, Tateno S, Nakamura Y, Zang WJ, Itoh M, Matsuura H, Minoru Horie (2012) Phenotype variability in patients carrying KCNJ2 mutations. Circ Cardiovasc Genet 5:344–353CrossRefPubMed Kimura H, Zhou J, Kawamura M, Itoh H, Mizusawa Y, Ding WG, Wu J, Ohno S, Makiyama T, Miyamoto A, Naiki N, Wang Q, Xie Y, Suzuki T, Tateno S, Nakamura Y, Zang WJ, Itoh M, Matsuura H, Minoru Horie (2012) Phenotype variability in patients carrying KCNJ2 mutations. Circ Cardiovasc Genet 5:344–353CrossRefPubMed
11.
Zurück zum Zitat Kawashiri M, Hayashi K, Konno T, Fujino N, Ino H, Yamagishi M (2014) Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects. Heart Vessel 29:129–141CrossRef Kawashiri M, Hayashi K, Konno T, Fujino N, Ino H, Yamagishi M (2014) Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects. Heart Vessel 29:129–141CrossRef
12.
Zurück zum Zitat Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ (2004) Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 110:2119–2124CrossRefPubMed Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ (2004) Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 110:2119–2124CrossRefPubMed
13.
Zurück zum Zitat Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C (2013) HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 10(12):1932–1963CrossRefPubMed Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C (2013) HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 10(12):1932–1963CrossRefPubMed
14.
Zurück zum Zitat Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106:69–74CrossRefPubMed Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106:69–74CrossRefPubMed
Metadaten
Titel
Prominent QTc prolongation in a patient with a rare variant in the cardiac ryanodine receptor gene
verfasst von
Yuki Taniguchi
Aya Miyazaki
Heima Sakaguchi
Yousuke Hayama
Norihiro Ebishima
Jun Negishi
Kanae Noritake
Yoshihiro Miyamoto
Wataru Shimizu
Takeshi Aiba
Hideo Ohuchi
Publikationsdatum
11.07.2016
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 2/2017
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-016-0869-z

Weitere Artikel der Ausgabe 2/2017

Heart and Vessels 2/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.